Antihypertensive Response to Losartan and Genetic Polymorphisms

NCT00617877 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
800
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Merck Sharp & Dohme LLC